It's official! 🎉 NERx is thrilled to announce the details of our $2MM NIH phase 2 grant to develop first in class cancer therapeutics awarded by the @theNCI
Read the full press release below!
https://t.co/bepgvtAWgu
The @IUCancerCenter is taking on lung cancer from every angle. With a $20 million gift from Julie Wood in honor of her late husband, Tom Wood, The Tom and Julie Wood Center for Lung Cancer Research was established in March 2024. Learn more: https://t.co/LoQxQkudT9.
Shadia Jalal (@ShadiaJalal), MD, and Catherine Sears (@PulmOncSears) MD, with the @IUCancerCenter and the @IndyVAMC, have been awarded a three-year, $1 million grant to expand lung cancer screenings to veterans across Indiana. Learn more: https://t.co/20Rci0yy3N.
Grateful of presenting our new generation of Ku-DBi’s and their unique mechanism of action of DNA-PK inhibition at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston. B068 #Targets23#IUSOM#turchilab#NERx#cancer#DDR
I've added this new thing to my collection of jobs, Editor in Chief of the brand new journal, NAR Molecular Medicine
To all my friends and colleagues in the DNA & RNA worlds - help us build this as a home for your best work connecting molecular mechanisms and human disease
Assistant Professor (tenure-track) @IUPUIBiology
Tenure-track faculty position in the Department of Biology at Indiana University Purdue University Indianapolis (IUPUI).
https://t.co/Yjr7Ku89bJ
#ScienceJobs#job
Indianapolis #UnitedStatesUS#Fac...
https://t.co/Yjr7Ku89bJ
Online Now: RNA:DNA hybrids from Okazaki fragments contribute to establish the Ku-mediated barrier to replication-fork degradation https://t.co/iun7ORVOsf
Dear Midwestern DNA repair aficionados, after Covid disruption the Midwest DNA repair symposium is finally back!
https://t.co/rDaX9fWYXk
To be considered for a talk, you need to register by April 1st.
Anna, Sarit and I are looking forward seeing you all in Iowa City
I am pleased to announce our most recent work on Ku-DNA binding inhibition and combination with DNA-DSB inducing agents to modulate the DDR via ATM and p53-dependent cell death. https://t.co/AmdCLND8AV #turchilab#NERx@johnturchi@NAR_Cancer_EIC